International Waldenstrom’s Macroglobulinemia Foundation



In the past few years there has been an explosion of research and discoveries in immunologic and genetic aspects of WM. The IWMF is pleased to provide the latest information for two treatment options for WM:  acalabrutinib and rituximab. The Fact Sheets for these treatments are available in multiple languages: English, Traditional and Simplified Chinese, German, Spanish, French, Italian, and Norwegian. These can be downloaded HERE.